メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Avkare, Inc.
B. Braun Melsungen AG
Beckersmith Medical, Inc.
Elekta AB
Heritage Pharmaceuticals Inc.
Ingenus Pharmaceuticals
Integra LifeSciences Corporation
Johnson & Johnson Services, Inc.
Lannett Company, Inc.
Magstim
Medtronic
MercuryPharma
Nostrum Laboratories Inc.
Novast Holdings Ltd.
Phoenix Biomedical Corp.
Sanofi, SGPharma Pvt. Ltd.
Sophysa
Taro Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
West-Ward Pharmaceutical
Zydus Pharmaceuticals, Inc.
Pseudotumor Cerebri Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Pseudotumor Cerebri
1.1 Pseudotumor Cerebri Market Overview
1.1.1 Pseudotumor Cerebri Product Scope
1.1.2 Market Status and Outlook
1.2 Global Pseudotumor Cerebri Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Pseudotumor Cerebri Market by Type
1.3.1 Fundoscopy
1.3.2 Neuroimaging
1.3.3 Lumbar Puncture
1.4 Pseudotumor Cerebri Market by End Users/Application
1.4.1 Spinal Fluid Shunt
1.4.2 Optic Nerve Sheath Fenestration
1.4.3 Venous Sinus Stenting
1.4.4 Medication
2 Global Pseudotumor Cerebri Competition Analysis by Players
2.1 Pseudotumor Cerebri Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Avkare, Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.1.5 Recent Developments
3.2 B. Braun Melsungen AG
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.2.5 Recent Developments
3.3 Beckersmith Medical, Inc.
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.3.5 Recent Developments
3.4 Elekta AB
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.4.5 Recent Developments
3.5 Heritage Pharmaceuticals Inc.
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.5.5 Recent Developments
3.6 Ingenus Pharmaceuticals
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.6.5 Recent Developments
3.7 Integra LifeSciences Corporation
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.7.5 Recent Developments
3.8 Johnson & Johnson Services, Inc.
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.8.5 Recent Developments
3.9 Lannett Company, Inc.
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.9.5 Recent Developments
3.10 Magstim
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Pseudotumor Cerebri Revenue (Value) (2015-2020)
3.10.5 Recent Developments
3.11 Medtronic
3.12 MercuryPharma
3.13 Nostrum Laboratories Inc.
3.14 Novast Holdings Ltd.
3.15 Phoenix Biomedical Corp.
3.16 Sanofi, SGPharma Pvt. Ltd.
3.17 Sophysa
3.18 Taro Pharmaceutical Industries Ltd.
3.19 Teva Pharmaceutical Industries Ltd.
3.20 West-Ward Pharmaceutical
3.21 Zydus Pharmaceuticals, Inc.
4 Global Pseudotumor Cerebri Market Size by Type and Application (2015-2020)
4.1 Global Pseudotumor Cerebri Market Size by Type (2015-2020)
4.2 Global Pseudotumor Cerebri Market Size by Application (2015-2020)
4.3 Potential Application of Pseudotumor Cerebri in Future
4.4 Top Consumer/End Users of Pseudotumor Cerebri
5 North America Pseudotumor Cerebri Development Status and Outlook
5.1 North America Pseudotumor Cerebri Market Size (2015-2020)
5.2 North America Pseudotumor Cerebri Market Size and Market Share by Players (2018 and 2019)
6 Europe Pseudotumor Cerebri Development Status and Outlook
6.1 Europe Pseudotumor Cerebri Market Size (2015-2020)
6.2 Europe Pseudotumor Cerebri Market Size and Market Share by Players (2018 and 2019)
7 China Pseudotumor Cerebri Development Status and Outlook
7.1 China Pseudotumor Cerebri Market Size (2015-2020)
7.2 China Pseudotumor Cerebri Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Pseudotumor Cerebri Development Status and Outlook
8.1 Rest of Asia Pacific Pseudotumor Cerebri Market Size (2015-2020)
8.2 Rest of Asia Pacific Pseudotumor Cerebri Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Pseudotumor Cerebri Development Status and Outlook
9.1 Central & South America Pseudotumor Cerebri Market Size (2015-2020)
9.2 Central & South America Pseudotumor Cerebri Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Pseudotumor Cerebri Development Status and Outlook
10.1 Middle East & Africa Pseudotumor Cerebri Market Size (2015-2020)
10.2 Middle East & Africa Pseudotumor Cerebri Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2021-2028)
11.1 Global Pseudotumor Cerebri Market Size (Value) by Regions (2021-2028)
11.1.1 North America Pseudotumor Cerebri Revenue and Growth Rate (2021-2028)
11.1.2 Europe Pseudotumor Cerebri Revenue and Growth Rate (2021-2028)
11.1.3 China Pseudotumor Cerebri Revenue and Growth Rate (2021-2028)
11.1.4 Rest of Asia Pacific Pseudotumor Cerebri Revenue and Growth Rate (2021-2028)
11.1.5 Central & South America Pseudotumor Cerebri Revenue and Growth Rate (2021-2028)
11.1.6 Middle East & Africa Pseudotumor Cerebri Revenue and Growth Rate (2021-2028)
11.2 Global Pseudotumor Cerebri Market Size (Value) by Type (2021-2028)
11.3 Global Pseudotumor Cerebri Market Size by Application (2021-2028)
12 Pseudotumor Cerebri Market Dynamics
12.1 Pseudotumor Cerebri Market Opportunities
12.2 Pseudotumor Cerebri Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Pseudotumor Cerebri Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Pseudotumor Cerebri Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source